Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.
Saved in:
| Title: | Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice. |
|---|---|
| Authors: | Fang J; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China., Cui E; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China., Xie J; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Gao X; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., He Y; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Yang M; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Shaheen S; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Zhou Z; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Zhou S; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Cheng B; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, China., Ling C; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, China., Ling C; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Aug 01; Vol. 16, pp. 1587135. Date of Electronic Publication: 2025 Aug 01 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1587135 |
